Discovering tumor vulnerabilities linked to targeted therapy-induced trans-differentiation: ferroptosis sensitivity in melanoma and small cell neuroendocrine cancers
Speaker: Thomas Graeber, PhD, Director, UCLA Metabolomics Center; Professor, Molecular & Medical Pharmacology, UCLA
This seminar is sponsored by the UCSF Helen Diller Family Comprehensive Center and hosted by Jean Nakamura, MD. Streaming link to be posted shortly before the event.
Friday, October 2 at 3:00pm to 4:00pmVirtual Event